MedPath
NMPA Approval

Velaglucerase Alfa for Injection

国药准字SJ20210013

April 27, 2021

Drug Information

注射用维拉苷酶α

维葡瑞

注射剂

目标装量为4.4ml,每瓶的总含量为11mg或440U维拉苷酶α。用4.3ml无菌注射用水复溶后,每瓶将提供4.0ml可抽取体积,其中含有10mg或400U维拉苷酶α。

生物制品

April 27, 2021

April 26, 2026

Company Information

Applicant Company

Block 2 Miesian Plaza, 50–58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

Manufacturing Company

vetter pharma-fertigung gmbh & co.kg

Mooswiesen 2, 88214, Ravensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath